Diseases, Conditions, Syndromes

Pfizer/BioNTech to develop mRNA-based shingles shot

Germany's BioNTech and US pharma giant Pfizer, which together developed a COVID-19 vaccine in record time, said Wednesday they are working on a shingles shot using the same mRNA technology.

Diseases, Conditions, Syndromes

What makes an mRNA vaccine so effective against severe COVID-19?

The first two vaccines created with mRNA vaccine technology—the Pfizer/BioNTech and Moderna COVID-19 vaccines—are arguably two of the most effective COVID vaccines developed to date. In clinical trials, both were more ...

Diseases, Conditions, Syndromes

Novavax COVID-19 vaccine found to be safe and effective

An investigational COVID-19 vaccine made by Novavax was found to be 90 percent effective at preventing COVID-19 illness, according to results from a Phase 3 clinical trial published today in the New England Journal of Medicine. ...

Vaccination

West African nations need to ramp up COVID-19 vaccination 10-fold

West African nations need to drastically ramp up their COVID-19 vaccination programmes by factor of 10 if they are to reach at least 60% coverage by 2022 and achieve the population level immunity needed to bring the pandemic ...

Oncology & Cancer

COVID-19 vaccine effective in people with cancer

The mRNA-based COVID-19 vaccines are effective at preventing infection in most cancer patients, according to a nationwide study of veterans diagnosed with cancer in the past decade.

page 20 from 40